摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-Fuoro-N,N-dimethylpyridin-3-amine | 1823624-32-3

中文名称
——
中文别名
——
英文名称
6-Fuoro-N,N-dimethylpyridin-3-amine
英文别名
6-fluoro-N,N-dimethylpyridin-3-amine
6-Fuoro-N,N-dimethylpyridin-3-amine化学式
CAS
1823624-32-3
化学式
C7H9FN2
mdl
——
分子量
140.16
InChiKey
PNLGUGDMFMBFKY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    16.1
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335

文献信息

  • FUSED PYRIMIDINE COMPOUNDS AND USE THEREOF
    申请人:MEDIVATION TECHNOLOGIES, INC.
    公开号:US20160068513A1
    公开(公告)日:2016-03-10
    Fused pyrimidine compounds as kinase inhibitors, such as multi-kinase inhibitors, are provided. Fused pyrimidine compounds as IGF-IR inhibitors are provided. Fused pyrimidine compounds that are inhibitors of Trk receptors (e.g., Trk A, Trk B and Trk C) are provided also. The compounds may be used in a method of treating cancer. Pharmaceutical compositions containing a fused pyrimidine compound and a pharmaceutically acceptable carrier are also provided, as are kits containing a fused pyrimidine compound or salt thereof and instructions for use, e.g., in a method of treating cancer.
    提供了作为激酶抑制剂的融合嘧啶化合物,例如多激酶抑制剂。提供了作为IGF-IR抑制剂的融合嘧啶化合物。还提供了抑制Trk受体(例如Trk A,Trk B和Trk C)的融合嘧啶化合物。这些化合物可以用于治疗癌症的方法。还提供了含有融合嘧啶化合物和药用载体的制药组合物,以及包含融合嘧啶化合物或其盐和使用说明的试剂盒,例如用于治疗癌症的方法。
  • N-HETEROCYCLIC METHYLPROPYLAMINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND GERMICIDES
    申请人:KUREHA KAGAKU KOGYO KABUSHIKI KAISHA
    公开号:EP1020441A1
    公开(公告)日:2000-07-19
    N-heterocyclicmethylpropylamine derivatives of formula (I): and acid addition salts thereof; wherein R1 represents hydrogen, halogen, alkyl, alkenyl, halogenated alkyl, alkoxy, halogenated alkoxy, hydroxyl, cyano, nitro, phenyl optionally having a substituent on a ring thereof or phenoxy; n represents an integer of 0-5; R2 represents a heterocycle containing at least one nitrogen atom as the hetero atom and optionally having a substituent on a ring thereof; and R3 represents hydrogen or C1-C5 alkyl.
    式(I)的 N-杂环甲基丙胺生物: 及其酸加成盐; 其中 R1 代表、卤素、烷基、基、卤代烷基、烷基、卤代烷基、羟基、基、硝基、可选择在其环上具有取代基的基或基;n 代表 0-5 的整数;R2 代表至少含有一个原子作为杂原子并可选择在其环上具有取代基的杂环;以及 R3 代表或 C1-C5 烷基。
  • N-(HETEROCYCLE-METHYL)ALKYLAMINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND BACTERICIDE
    申请人:Kureha Chemical Industry Co., Ltd.
    公开号:EP1391450A1
    公开(公告)日:2004-02-25
    A N-heterocyclicmethyl-alkylamine derivative according to the present invention is a N-heterocyclicmethyl-alkylamine derivative represented by the following general formula (I): or an acid addition salt thereof. [in the formula, R1 represents a heterocycle which has at least one nitrogen atom as a hetero atom and may have a substituent on a ring; R2 represents a hydrogen or the like; R3 represents an alkyl group having a carbon number of 1 to 5 or the like; R4 represents an alkyl group having a carbon number of 1 to 5 or the like; when R4 is an alkyl group having a carbon number of 1 to 5 or a halogenated alkyl group having a carbon number of 1 to 5, carbon atoms in R3 and R4 may be bonded to form a ring structure; m represents an integer of 1 to 3; R5 represents a cycloalkyl group or the like described by the following formula (III): (in the formula, Y and Z each represents a hydrogen atom or the like, the letter p represents an integer of 2 to 5, and the groups described by CYZ may be each the same or different), when m is 1 and R4 is a hydrogen atom, R5 is a cycloalkyl group describedby the foregoing formula (III).]
    根据本发明,N-杂环甲基-烷基胺衍生物是由以下通式(I)代表的 N-杂环甲基-烷基胺衍生物: 或其酸加成盐。 [式中,R1 代表杂环,该杂环至少有一个原子作为杂原子,并可在环上有取代基;R2 代表或类似物;R3 代表原子数为 1 至 5 的烷基或类似物;R4 代表原子数为 1 至 5 的烷基或类似物;当 R4 是原子数为 1 至 5 的烷基或原子数为 1 至 5 的卤代烷基时,R3 和 R4 中的原子可以键合形成环状结构;m 代表 1 至 3 的整数;R5 代表下式(III)所述的环烷基或类似基团: (式中,Y 和 Z 分别代表原子或类似物,字母 p 代表 2 至 5 的整数,CYZ 所述基团可以相同或不同),当 m 为 1 且 R4 为原子时,R5 为前式(III)所述的环烷基]。
  • N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide
    申请人:Ito Atsushi
    公开号:US20050101783A1
    公开(公告)日:2005-05-12
    A N-heterocyclicmethyl-alkylamine derivative according to the present invention is a N-heterocyclicmethyl-alkylamine derivative represented by the following general formula (I): or an acid addition salt thereof. [in the formula, R 1 represents a heterocycle which has at least one nitrogen atom as a hetero atom and may have a substituent on a ring; R 2 represents a hydrogen or the like; R 3 represents an alkyl group having a carbon number of 1 to 5 or the like; R 4 represents an alkyl group having a carbon number of 1 to 5 or the like; when R 4 is an alkyl group having a carbon number of 1 to 5 or a halogenated alkyl group having a carbon number of 1 to 5, carbon atoms in R 3 and R 4 may be bonded to form a ring structure; m represents an integer of 1 to 3; R 5 represents a cycloalkyl group or the like described by the following formula (III): (in the formula, Y and Z each represents a hydrogen atom or the like, the letter p represents an integer of 2 to 5, and the groups described by CYZ may be each the same or different), when m is 1 and R 4 is a hydrogen atom, R 5 is a cycloalkyl group described by the foregoing formula (III).]
    根据本发明,N-杂环甲基-烷基胺衍生物是由以下通式(I)代表的 N-杂环甲基-烷基胺衍生物: 或其酸加成盐。 [式中,R 1 代表至少有一个原子作为杂原子的杂环,并可在环上有取代基;R 2 代表或类似物;R 3 代表原子数为 1 至 5 的烷基或类似物; R 4 代表原子数为 1 至 5 的烷基或类似物;当 R 4 是原子数为 1 至 5 的烷基或原子数为 1 至 5 的卤代烷基时,R 3 和 R 4 中的原子可以键合形成环状结构;m 代表 1 至 3 的整数;R 5 代表下式(III)所述的环烷基或类似基团: (式中,Y 和 Z 分别代表原子或类似物,字母 p 代表 2 至 5 的整数,CYZ 所述基团可以相同或不同),当 m 为 1 且 R 4 是原子时,R 5 是前述式 (III) 所述的环烷基]。
  • US6271385B1
    申请人:——
    公开号:US6271385B1
    公开(公告)日:2001-08-07
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-